Category: Blogs

Crohn's Disease Epidemiology Prevalence And Market Trends Analysis By DelveInsight As per DelveInsight, in 2020, the Crohn’s Disease prevalence in the United States was approximately 825,165, which is expected to increase steadily in the coming decade. Crohn’s Disease Market is expected to expand modestly owing to the continuous research and developments activities and innovation in therapies delivery platforms, MoAs, and RoAs. Some of the key pharmaceutical companies developing novel therapies to combat the unmet needs prevailing in the Crohn’s Disease Therapeutics space include Eli Lilly, RedHill Biopharma Ltd., AbbVie, and Boehringer Ingelheim, Gilead Sciences, Galapagos, Celgene, The Janssen Pharmaceutical Companies of Johnson & Johnson, among several others.